Skip to main content

Table 2 Allele frequency of SNPs associated with drug resistancea

From: Whole genome sequencing analysis to evaluate the influence of T2DM on polymorphisms associated with drug resistance in M. tuberculosis

Antibiotic resistance

Gene

Aminoacid change

Frequency

T2DMb

(n = 74)

n(%)

Frequency

TBc

(n = 74)

n(%)

Frequency

Total

(n = 148)

n(%)

Isoniazid

katG

S315T

44 (59.4%)

47 (63.5%)

91 (61.4%)

fabG1-inhA

c15t

28 (37.8%)

34 (45.9%)

62 (41.8%)

Rifampicin

rpoB

S450L

28 (37.8%)

30 (40.5%)

58 (39.1%)

rpoB

H445D

5 (6.7%)

11 (14.8%)

16 (10.8%)

rpoB

D435Y

2 (2.7%)

6 (8.1%)

8 (5.4%)

rpoB

H445L

4 (5.4%)

0

4 (2.7%)

rpoB

S441L

1 (1.3%)

0

1 (0.6%)

rpoB

Q432P

1 (1.3%)

0

1 (0.6%)

rpoB

Q432L

1 (1.3%)

0

1 (0.6%)

rpoC

V483G

8 (10.8%)

10 (13.5%)

18 (12.1%)

rpoC

V483A

3 (4.0%)

2 (2.7%)

5 (3.38%)

Streptomycin

rpsL

K88R

7 (9.4%)

15 (20.2%)

22 (14.8%)

rpsL

K43R

4 (5.4%)

14 (18.9%)

18 (12.1%)

Ethambutol

embB

M306I

12 (16.2%)

9 (12.1%)

21 (14.1%)

embB

Q497R

5 (6.7%)

12 (16.2%)

17 (11.4%)

embB

S297A

4 (5.4%)

9 (12.1%)

13 (8.7%)

Pyrazinamide

pncA

D49G

5 (6.7%)

6 (8.1%)

11 (7.4%)

pncA

L120P

7 (9.4%)

2 (2.7%)

9 (6.8%)

Fluoroquinolone

gyrA

A90V

4 (5.4%)

6 (8.1%)

10 (6.7%)

gyrA

D94G

4 (5.4%)

3 (4.0%)

8 (5.4%)

  1. aSNPs with a proportion greater than 3% in the sample (n = 148), bT2DM: Host with diabetes mellitus type 2 and tuberculosis
  2. cTB: Host without diabetes mellitus type 2 and tuberculosis